Floatz logo

Enoxaparin

VTE (Venous Thromboembolism)

University College Dublinother_biologicalPhase 4 / ApprovedActive
BBB
78/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the VTE (Venous Thromboembolism) cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
Shanghai Pulmonary Hospital, Shanghai, China
Phase 4BB

Same molecule, other indications

Enoxaparin is also rated in:

thrombophlebitisDormant
BBB
Indicative ·
74 / 100
View asset →
traumatic brain injuryDormant
BB
Indicative ·
67 / 100
View asset →
venous thromboembolismDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →